Jeffrey Eisele - Jan 28, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Exec VP, Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Stock symbol
APLS
Transactions as of
Jan 28, 2022
Transactions value $
-$16,748
Form type
4
Date filed
2/1/2022, 05:09 PM
Previous filing
Jan 25, 2022
Next filing
Dec 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$16.7K -434 -1.3% $38.59 33K Jan 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.